AstraZeneca’s $ 39 billion takeover of rare disease specialist Alexion has another regulatory blessing in the bag, but the pair are still holding out for a key nod from the U.K. to settle the deal. AstraZeneca on Tuesday said that the European Union has approved its acquisition of Boston-based Alexion, inching closer toward its goal… Read More »
Telehealth demonstrated its potential value as a way to supplement medical care during the pandemic, greatly improving access and accessibility, and is likely here to stay. But, experts said at a panel this week, changes in regulatory oversight and technological upgrades will be needed to ensure that the already marginalized — the elderly, the poor,… Read More »
Jacob Jeppson, Director of Analysis, Arch Collaborative, KLAS In a time when it seemed we couldn’t have been further apart, what we needed was to come together — intellectually speaking, that is. At the beginning of the pandemic, before everything shut down, we were fortunate enough to be preparing for our committee meetings with Arch… Read More »
JOHANNESBURG (AP) — At this very moment a vast world exists that’s free of the coronavirus, where people can mingle without masks and watch the pandemic unfold from thousands of miles away. That world is Antarctica, the only continent without COVID-19. Now, as nearly 1,000 scientists and others who wintered over on the ice are… Read More »
The novel coronavirus is a mysterious virus. Because it is new, there is very little information about the virus, which causes COVID-19 infection among the people. Millions have been infected so far, and the pandemic has halted regular life. Amid all this, scientists are continuously trying to find as many answers as possible about the… Read More »